Metastatic Melanoma, BRAF V600 Mutation Positive
2 clinical trials · Condition
◉ Watch Metastatic Melanoma, BRAF V600 Mutation Positive
| Record | Firm | Date |
|---|---|---|
| UK ENcorafenib and BInimetinib Real-world Study in Melanoma (NCT07022457) | Pierre Fabre Ltd | 2025-07-31 |
| A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State (NCT02608034) | Genentech, Inc. | 2016-05-26 |
Track Metastatic Melanoma, BRAF V600 Mutation Positive automatically
Every clearance here is in the API, with alerts when new ones post.